These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21671081)

  • 1. Familial colorectal cancer: eleven years of data from a registry program in Switzerland.
    Kovac M; Laczko E; Haider R; Jiricny J; Mueller H; Heinimann K; Marra G
    Fam Cancer; 2011 Sep; 10(3):605-16. PubMed ID: 21671081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
    Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.
    Walsh MD; Buchanan DD; Cummings MC; Pearson SA; Arnold ST; Clendenning M; Walters R; McKeone DM; Spurdle AB; Hopper JL; Jenkins MA; Phillips KD; Suthers GK; George J; Goldblatt J; Muir A; Tucker K; Pelzer E; Gattas MR; Woodall S; Parry S; Macrae FA; Haile RW; Baron JA; Potter JD; Le Marchand L; Bapat B; Thibodeau SN; Lindor NM; McGuckin MA; Young JP
    Clin Cancer Res; 2010 Apr; 16(7):2214-24. PubMed ID: 20215533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations.
    Wijnen J; Khan PM; Vasen H; van der Klift H; Mulder A; van Leeuwen-Cornelisse I; Bakker B; Losekoot M; Møller P; Fodde R
    Am J Hum Genet; 1997 Aug; 61(2):329-35. PubMed ID: 9311737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis.
    Sekine S; Mori T; Ogawa R; Tanaka M; Yoshida H; Taniguchi H; Nakajima T; Sugano K; Yoshida T; Kato M; Furukawa E; Ochiai A; Hiraoka N
    Mod Pathol; 2017 Aug; 30(8):1144-1151. PubMed ID: 28548127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
    Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
    JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.
    Wang Q; Lasset C; Desseigne F; Saurin JC; Maugard C; Navarro C; Ruano E; Descos L; Trillet-Lenoir V; Bosset JF; Puisieux A
    Hum Genet; 1999; 105(1-2):79-85. PubMed ID: 10480359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset colorectal cancer is an easy and effective tool to identify retrospectively Lynch syndrome.
    Perea J; Rodríguez Y; Rueda D; Marín JC; Díaz-Tasende J; Álvaro E; Alegre C; Osorio I; Colina F; Lomas M; Hidalgo M; Benítez J; Urioste M
    Ann Surg Oncol; 2011 Nov; 18(12):3285-91. PubMed ID: 21590452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
    Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
    Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer.
    Heinimann K; Scott RJ; Buerstedde JM; Weber W; Siebold K; Attenhofer M; Müller H; Dobbie Z
    Cancer; 1999 Jun; 85(12):2512-8. PubMed ID: 10375096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.
    Lindor NM
    Surg Oncol Clin N Am; 2009 Oct; 18(4):637-45. PubMed ID: 19793571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of pancreatic cancer in families with Lynch syndrome.
    Kastrinos F; Mukherjee B; Tayob N; Wang F; Sparr J; Raymond VM; Bandipalliam P; Stoffel EM; Gruber SB; Syngal S
    JAMA; 2009 Oct; 302(16):1790-5. PubMed ID: 19861671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.